marketcaparena
Search

    MD

    Pediatrix Medical Group, Inc.

    Company overview

    Market capitalization
    $2.13B
    Employees
    4,280
    Latest publication
    2026-09-29
    About Pediatrix Medical Group, Inc.

    Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue476,196,000USD493,771,000USD492,875,000USD468,844,000USD458,359,000USD502,364,000USD511,158,000USD504,296,000USD
    Selling General Administrative60,266,000USD—60,793,000USD55,714,000USD58,604,000USD—58,121,000USD56,565,000USD
    General And Administrative Expenses60,266,000USD—60,793,000USD55,714,000USD58,604,000USD—58,121,000USD56,565,000USD
    Total Operating Expenses434,539,000USD444,977,000USD424,824,000USD408,977,000USD426,258,000USD463,073,000USD477,331,000USD662,019,000USD
    Operating Income41,657,000USD—68,051,000USD59,867,000USD32,101,000USD—33,827,000USD-157,723,000USD
    Total Other Income Expense Net-2,813,000USD—19,727,000USD-4,898,000USD-4,011,000USD—-8,592,000USD-10,005,000USD
    Interest Expense8,265,000USD—8,941,000USD9,130,000USD9,154,000USD—10,126,000USD10,308,000USD
    Income Before Tax38,844,000USD—87,778,000USD54,969,000USD28,090,000USD—25,235,000USD-167,728,000USD
    Income Tax Expense9,272,000USD11,912,000USD16,070,000USD15,709,000USD7,353,000USD2,848,000USD5,794,000USD-14,703,000USD
    Equity Method Income Loss692,000USD—1,879,000USD505,000USD406,000USD—445,000USD464,000USD
    Net Income29,572,000USD33,683,000USD71,708,000USD39,260,000USD20,737,000USD30,480,000USD19,441,000USD-153,025,000USD
    SourceDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinalDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,913,849,000USD2,012,919,000USD1,994,640,000USD1,972,021,000USD1,911,191,000USD1,733,951,000USD3,513,542,000USD3,647,123,000USD
    Selling General Administrative240,791,000USD238,437,000USD227,542,000USD231,397,000USD263,357,000USD248,947,000USD404,643,000USD432,378,000USD
    General And Administrative Expenses240,791,000USD238,437,000USD227,542,000USD231,397,000USD263,357,000USD248,947,000USD404,643,000USD432,378,000USD
    Total Operating Expenses1,705,036,000USD2,081,632,000USD1,987,319,000USD1,799,333,000USD1,708,273,000USD1,635,819,000USD4,649,591,000USD3,201,275,000USD
    Operating Income208,813,000USD-68,713,000USD7,321,000USD172,688,000USD202,918,000USD98,132,000USD-1,136,049,000USD445,848,000USD
    Total Other Income Expense Net7,619,000USD-32,628,000USD-55,680,000USD-91,318,000USD-67,690,000USD-90,984,000USD-105,931,000USD-77,009,000USD
    Interest Expense35,965,000USD40,743,000USD42,075,000USD39,695,000USD68,722,000USD110,482,000USD119,381,000USD88,769,000USD
    Income Before Tax216,432,000USD-101,341,000USD-48,359,000USD81,370,000USD135,228,000USD7,148,000USD-1,241,980,000USD368,839,000USD
    Income Tax Expense51,044,000USD-2,272,000USD12,049,000USD18,806,000USD27,241,000USD16,728,000USD-91,886,000USD100,210,000USD
    Equity Method Income Loss3,633,000USD2,344,000USD2,057,000USD1,722,000USD1,912,000USD1,585,000USD7,779,000USD6,825,000USD
    Net Income165,388,000USD-99,069,000USD-60,408,000USD66,331,000USD130,937,000USD-796,488,000USD-1,497,702,000USD268,629,000USD
    Discontinued Operations—0USD0USD3,767,000USD22,950,000USD-786,908,000USD-347,608,000USD—
    Minority Interest—0USD0USD-4,000USD27,000USD———
    Net Income Applicable To Common Shares———66,335,000USD130,964,000USD———
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets2,070,295,000USD2,246,696,000USD2,199,405,000USD2,102,100,000USD1,993,479,000USD2,152,700,000USD2,076,873,000USD1,995,351,000USD
    Cash And Equivalents205,780,000USD375,241,000USD340,059,000USD224,732,000USD98,978,000USD229,940,000USD103,831,000USD19,402,000USD
    Total Current Assets587,034,000USD763,514,000USD717,195,000USD613,050,000USD491,670,000USD639,607,000USD528,215,000USD429,212,000USD
    Other Current Assets8,205,000USD8,879,000USD10,215,000USD7,678,000USD7,608,000USD5,087,000USD9,480,000USD9,941,000USD
    Other Non Current Assets55,403,000USD58,156,000USD57,889,000USD70,785,000USD71,349,000USD76,598,000USD78,594,000USD79,539,000USD
    Total Liabilities1,191,719,000USD1,380,842,000USD1,308,739,000USD1,268,347,000USD1,204,291,000USD1,387,762,000USD1,344,381,000USD1,288,890,000USD
    Total Current Liabilities442,638,000USD458,911,000USD392,547,000USD341,043,000USD271,052,000USD434,110,000USD373,080,000USD310,156,000USD
    Other Non Current Liabilities29,721,000USD30,336,000USD33,526,000USD33,297,000USD30,859,000USD32,887,000USD33,035,000USD31,521,000USD
    Total Stockholder Equity878,576,000USD865,854,000USD890,666,000USD833,753,000USD789,188,000USD764,938,000USD732,492,000USD706,461,000USD
    Total Equity Including Noncontrolling Interest878,576,000USD865,854,000USD890,666,000USD833,753,000USD789,188,000USD764,938,000USD732,492,000USD706,461,000USD
    Long Term Debt398,348,000USD570,532,000USD577,169,000USD583,863,000USD590,476,000USD597,119,000USD——
    Net Receivables224,801,000USD229,665,000USD231,122,000USD238,992,000USD242,529,000USD259,990,000USD286,897,000USD274,164,000USD
    Property Plant Equipment Net41,094,000USD70,312,000USD38,636,000USD38,944,000USD38,222,000USD73,261,000USD41,922,000USD47,893,000USD
    Goodwill1,268,248,000USD1,260,732,000USD1,255,423,000USD1,242,606,000USD1,242,606,000USD1,242,606,000USD1,239,007,000USD1,239,007,000USD
    Accounts Payable31,537,000USD37,220,000USD38,652,000USD42,065,000USD44,120,000USD46,431,000USD47,367,000USD32,000,000USD
    Short Term Debt11,885,000USD11,591,000USD12,226,000USD12,049,000USD12,174,000USD12,704,000USD16,992,000USD18,764,000USD
    Common Stock821,000USD830,000USD858,000USD869,000USD858,000USD859,000USD859,000USD858,000USD
    Retained Earnings-53,580,000USD-83,152,000USD-116,835,000USD-188,543,000USD-227,803,000USD-248,540,000USD-279,020,000USD-298,461,000USD
    Accumulated Other Comprehensive Income77,000USD610,000USD446,000USD137,000USD-292,000USD-1,071,000USD-209,000USD-1,954,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,246,696,000USD2,152,700,000USD2,219,810,000USD2,347,887,000USD2,722,546,000USD3,347,948,000USD4,145,901,000USD5,934,911,000USD
    Cash And Equivalents375,241,000USD229,940,000USD73,258,000USD9,824,000USD387,391,000USD1,123,843,000USD112,767,000USD36,745,000USD
    Total Current Assets763,514,000USD639,607,000USD483,454,000USD427,989,000USD840,564,000USD1,549,348,000USD731,507,000USD657,409,000USD
    Other Current Assets8,879,000USD5,087,000USD12,308,000USD13,261,000USD18,896,000USD61,806,000USD23,442,000USD17,706,000USD
    Other Non Current Assets58,156,000USD76,598,000USD82,165,000USD123,176,000USD131,028,000USD107,355,000USD89,994,000USD103,459,000USD
    Total Liabilities1,380,842,000USD1,387,762,000USD1,370,749,000USD1,456,255,000USD1,825,854,000USD2,600,231,000USD2,646,905,000USD2,847,027,000USD
    Total Current Liabilities458,911,000USD434,110,000USD388,946,000USD426,983,000USD427,366,000USD444,335,000USD541,818,000USD500,193,000USD
    Other Non Current Liabilities30,336,000USD32,887,000USD30,552,000USD39,411,000USD42,332,000USD45,320,000USD22,900,000USD32,254,000USD
    Total Stockholder Equity865,854,000USD764,938,000USD849,061,000USD891,632,000USD896,487,000USD747,485,000USD1,498,996,000USD3,087,884,000USD
    Total Equity Including Noncontrolling Interest865,854,000USD764,938,000USD849,061,000USD891,632,000USD896,692,000USD747,717,000USD1,498,996,000USD3,087,884,000USD
    Long Term Debt570,532,000USD597,119,000USD618,421,000USD—————
    Net Receivables229,665,000USD259,990,000USD272,313,000USD296,787,000USD301,775,000USD241,931,000USD498,869,000USD542,272,000USD
    Property Plant Equipment Net70,312,000USD73,261,000USD137,332,000USD129,086,000USD121,437,000USD121,117,000USD177,316,000USD133,037,000USD
    Goodwill1,260,732,000USD1,242,606,000USD1,384,166,000USD1,532,092,000USD1,505,430,000USD1,477,968,000USD2,710,292,000USD4,382,995,000USD
    Accounts Payable37,220,000USD46,431,000USD34,588,000USD31,857,000USD36,645,000USD59,771,000USD39,610,000USD31,059,000USD
    Short Term Debt11,591,000USD12,704,000USD21,076,000USD21,589,000USD19,684,000USD18,933,000USD23,317,000USD—
    Common Stock830,000USD859,000USD840,000USD829,000USD864,000USD856,000USD842,000USD878,000USD
    Retained Earnings-83,152,000USD-248,540,000USD149,471,000USD-89,063,000USD-155,390,000USD-286,354,000USD510,212,000USD2,094,359,000USD
    Accumulated Other Comprehensive Income610,000USD-1,071,000USD2,214,000USD-3,735,000USD1,317,000USD3,530,000USD——
    Cash And Short Term Investments——————112,767,000USD—
    Short Term Investments——————0USD—
    Long Term Investments——————0USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation6,119,000USD5,631,000USD5,551,000USD5,313,000USD5,332,000USD6,873,000USD6,254,000USD8,791,000USD
    Stock Based Compensation4,661,000USD5,345,000USD5,150,000USD3,909,000USD3,641,000USD2,739,000USD4,110,000USD1,952,000USD
    Deferred Income Tax8,342,000USD———4,398,000USD———
    Other Non Cash Items670,000USD-1,123,000USD-23,699,000USD-1,479,000USD758,000USD-7,342,000USD-3,893,000USD190,341,000USD
    Change To Account Receivables4,864,000USD1,457,000USD7,870,000USD3,770,000USD17,461,000USD9,657,000USD1,569,000USD9,002,000USD
    Change To Liabilities-187,030,000USD———-165,834,000USD———
    Change In Working Capital-21,217,000USD46,019,000USD67,440,000USD78,058,000USD-142,101,000USD86,510,000USD56,778,000USD84,606,000USD
    Operating Cash Flow-129,847,000USD———-117,463,000USD———
    Net Investments742,000USD———-461,000USD———
    Other Investing Activities-7,526,000USD———3,685,000USD———
    Unclassified Investing Cash Flow-5,195,000USD-4,000,000USD5,289,000USD4,466,000USD-10,688,000USD-1,036,000USD3,931,000USD12,892,000USD
    Investing Cash Flow-11,979,000USD———-7,464,000USD———
    Net Common Stock Issuance-21,451,000USD———-1,569,000USD———
    Other Financing Activities0USD———-101,000USD———
    Unclassified Financing Cash Flow-6,184,000USD——1,176,000USD-4,365,000USD——-82,677,000USD
    Financing Cash Flow-27,635,000USD———-6,035,000USD———
    Change In Cash-169,461,000USD35,182,000USD115,327,000USD125,754,000USD-130,962,000USD126,109,000USD84,429,000USD11,404,000USD
    End Cash Flow205,780,000USD———98,978,000USD———
    Net Income—33,683,000USD71,708,000USD39,260,000USD—30,480,000USD19,441,000USD-153,025,000USD
    Total Cash From Operating Activities—114,102,000USD137,285,000USD137,167,000USD—133,010,000USD91,838,000USD106,951,000USD
    Capital Expenditures—-5,287,000USD-5,338,000USD-4,515,000USD—-3,440,000USD-6,290,000USD-6,962,000USD
    Free Cash Flow—108,815,000USD131,947,000USD132,652,000USD—129,570,000USD85,548,000USD99,989,000USD
    Investments—-1,117,000USD6,604,000USD-7,154,000USD—-1,938,000USD-4,338,000USD-12,892,000USD
    Total Cashflows From Investing Activities—-10,282,000USD6,604,000USD-7,154,000USD—-1,938,000USD-4,338,000USD-12,892,000USD
    Net Borrowings—-5,341,000USD-5,190,000USD-5,192,000USD—-3,968,000USD-3,779,000USD—
    Total Cash From Financing Activities—-68,638,000USD-28,562,000USD-4,259,000USD—-4,963,000USD-3,071,000USD-82,655,000USD
    Sale Purchase Of Stock—-64,038,000USD-20,867,000USD-209,000USD—-643,000USD-162,000USD-11,000USD
    Issuance Of Capital Stock—646,000USD700,000USD1,176,000USD—732,000USD897,000USD1,149,000USD
    Begin Period Cash Flow—340,059,000USD224,732,000USD98,978,000USD—103,831,000USD19,402,000USD7,998,000USD
    End Period Cash Flow—375,241,000USD340,059,000USD224,732,000USD—229,940,000USD103,831,000USD19,402,000USD
    Other Cashflows From Investing Activities—122,000USD49,000USD49,000USD—4,476,000USD2,359,000USD-5,930,000USD
    Other Cashflows From Financing Activities—95,000USD-3,205,000USD-34,000USD—-1,084,000USD-27,000USD33,000USD
    Unclassified Operating Cash Flow—24,547,000USD11,135,000USD12,106,000USD—13,750,000USD9,148,000USD-25,714,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Depreciation21,827,000USD32,226,000USD36,171,000USD35,636,000USD32,147,000USD28,441,000USD78,860,000USD111,281,000USD
    Stock Based Compensation18,045,000USD11,868,000USD12,323,000USD16,127,000USD18,968,000USD39,042,000USD35,351,000USD38,703,000USD
    Deferred Income Tax52,186,000USD-2,130,000USD3,239,000USD-22,771,000USD-31,239,000USD36,292,000USD-177,000,000USD-24,149,000USD
    Other Non Cash Items4,562,000USD2,972,000USD3,167,000USD-57,160,000USD-12,182,000USD198,000USD-389,000USD10,903,000USD
    Change To Account Receivables30,558,000USD10,292,000USD26,276,000USD-5,543,000USD-72,731,000USD37,937,000USD7,854,000USD-36,598,000USD
    Change To Liabilities2,262,000USD28,456,000USD-40,429,000USD-19,579,000USD-1,192,000USD51,426,000USD75,674,000USD11,096,000USD
    Change In Working Capital50,484,000USD70,936,000USD-12,465,000USD26,227,000USD-24,879,000USD48,392,000USD87,400,000USD-92,625,000USD
    Operating Cash Flow271,091,000USD206,573,000USD137,325,000USD166,941,000USD76,737,000USD204,620,000USD346,637,000USD289,925,000USD
    Net Investments-3,177,000USD-12,052,000USD-8,988,000USD-457,000USD1,444,000USD-28,413,000USD16,004,000USD-2,174,000USD
    Other Investing Activities-19,731,000USD-8,167,000USD-6,667,000USD-28,167,000USD-29,930,000USD-2,225,000USD-111,975,000USD-114,491,000USD
    Unclassified Investing Cash Flow4,612,000USD-15,187,000USD-32,521,000USD-28,330,000USD-24,587,000USD846,149,000USD198,426,000USD-26,104,000USD
    Investing Cash Flow-18,296,000USD-35,406,000USD-48,176,000USD-56,954,000USD-53,073,000USD815,511,000USD102,455,000USD-142,769,000USD
    Net Common Stock Issuance-86,683,000USD-1,703,000USD-919,000USD-88,511,000USD-4,719,000USD-8,493,000USD-145,280,000USD-302,160,000USD
    Other Financing Activities-63,000USD135,000USD-8,773,000USD9,353,000USD596,000USD245,000USD0USD—
    Unclassified Financing Cash Flow-20,748,000USD-12,917,000USD-16,023,000USD-408,396,000USD-755,993,000USD4,090,000USD-247,790,000USD131,549,000USD
    Financing Cash Flow-107,494,000USD-14,485,000USD-25,715,000USD-487,554,000USD-760,116,000USD-4,158,000USD-393,070,000USD-170,611,000USD
    Change In Cash145,301,000USD156,682,000USD63,434,000USD-377,567,000USD-736,452,000USD1,015,973,000USD56,022,000USD-23,455,000USD
    End Cash Flow375,241,000USD229,940,000USD73,258,000USD———112,767,000USD56,745,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
    Depreciation16,196,000USD10,645,000USD25,353,000USD19,099,000USD27,109,000USD17,898,000USD26,500,000USD17,544,000USD
    Stock Based Compensation12,700,000USD7,550,000USD9,129,000USD5,019,000USD9,299,000USD6,135,000USD12,891,000USD8,771,000USD
    Deferred Income Tax27,639,000USD16,504,000USD-15,880,000USD-25,028,000USD10,589,000USD8,376,000USD-8,702,000USD-1,894,000USD
    Other Non Cash Items3,386,000USD1,501,000USD2,006,000USD1,678,000USD1,607,000USD900,000USD-54,637,000USD-55,439,000USD
    Change To Account Receivables29,101,000USD21,231,000USD635,000USD-934,000USD22,095,000USD28,900,000USD-501,000USD-15,950,000USD
    Change To Liabilities-51,453,000USD-99,266,000USD-56,186,000USD-94,547,000USD-72,618,000USD-107,671,000USD-86,748,000USD-91,853,000USD
    Change In Working Capital35,213,000USD-63,467,000USD-11,510,000USD-63,088,000USD-38,044,000USD-83,606,000USD-53,380,000USD-83,789,000USD
    Operating Cash Flow156,989,000USD19,704,000USD73,563,000USD-18,275,000USD68,075,000USD-11,863,000USD68,255,000USD-15,075,000USD
    Net Investments-2,060,000USD-3,149,000USD-9,078,000USD-8,671,000USD-9,917,000USD-4,951,000USD951,000USD1,056,000USD
    Other Investing Activities-15,609,000USD3,636,000USD-8,167,000USD-8,167,000USD-1,667,000USD-1,667,000USD-30,320,000USD-29,356,000USD
    Unclassified Investing Cash Flow9,655,000USD-15,105,000USD-16,223,000USD-12,292,000USD-24,168,000USD-15,130,000USD-16,344,000USD-11,325,000USD
    Investing Cash Flow-8,014,000USD-14,618,000USD-33,468,000USD-29,130,000USD-35,752,000USD-21,748,000USD-45,713,000USD-39,625,000USD
    Net Common Stock Issuance-22,645,000USD-1,778,000USD-1,060,000USD-898,000USD-919,000USD-786,000USD-87,041,000USD-65,600,000USD
    Other Financing Activities-158,000USD-135,000USD52,000USD79,000USD-8,445,000USD-1,613,000USD483,000USD284,000USD
    Unclassified Financing Cash Flow-16,053,000USD-8,381,000USD-8,514,000USD-5,632,000USD-11,604,000USD32,035,000USD-314,707,000USD-253,287,000USD
    Financing Cash Flow-38,856,000USD-10,294,000USD-9,522,000USD-6,451,000USD-20,968,000USD29,636,000USD-401,265,000USD-318,603,000USD
    Change In Cash110,119,000USD-5,208,000USD30,573,000USD-53,856,000USD11,355,000USD-3,975,000USD-378,723,000USD-373,303,000USD
    End Cash Flow340,059,000USD224,732,000USD103,831,000USD19,402,000USD21,179,000USD5,849,000USD8,668,000USD14,088,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductHealth Care Patient Service405,352,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductHospitals Contracts69,920,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductProduct And Service Other924,000USDDisclosure
    Q4 2025Quarterly · 2025-12-31ProductHealth Care Patient Service421,550,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductHospitals Contracts69,989,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct And Service Other2,232,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductHealth Care Patient Service1,630,517,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductHospitals Contracts271,125,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductProduct And Service Other12,207,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductHealth Care Patient Service422,179,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductHospitals Contracts67,728,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductProduct And Service Other2,968,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductHealth Care Patient Service397,410,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductHospitals Contracts68,224,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductProduct And Service Other3,210,000USDDisclosure
    Q1 2025Quarterly · 2025-03-31ProductHealth Care Patient Service389,378,000USDDisclosure
    Q1 2025Quarterly · 2025-03-31ProductHospitals Contracts65,184,000USDDisclosure
    Q1 2025Quarterly · 2025-03-31ProductProduct And Service Other3,797,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31ProductHealth Care Patient Service430,251,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31ProductHospitals Contracts71,555,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31ProductProduct And Service Other558,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductHealth Care Patient Service1,723,604,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductHospitals Contracts286,684,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductProduct And Service Other2,631,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Patient Service438,675,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductHospitals Contracts72,413,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductProduct And Service Other70,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Patient Service432,847,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductHospitals Contracts70,913,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductProduct And Service Other536,000USDDisclosure
    FY 2023Yearly · 2023-12-31ProductHealth Care Patient Service1,716,368,000USDDisclosure
    FY 2023Yearly · 2023-12-31ProductHospitals Contracts275,677,000USDDisclosure
    FY 2023Yearly · 2023-12-31ProductProduct And Service Other2,595,000USDDisclosure
    FY 2022Yearly · 2022-12-31ProductHealth Care Patient Service1,688,818,000USDDisclosure
    FY 2022Yearly · 2022-12-31ProductHospitals Contracts262,931,000USDDisclosure
    FY 2022Yearly · 2022-12-31ProductProduct And Service Other20,272,000USDDisclosure
    FY 2021Yearly · 2021-12-31ProductHealth Care Patient Service1,641,323,000USDDisclosure
    FY 2021Yearly · 2021-12-31ProductHospitals Contracts240,022,000USDDisclosure
    FY 2021Yearly · 2021-12-31ProductProduct And Service Other29,846,000USDDisclosure
    FY 2020Yearly · 2020-12-31ProductHealth Care Patient Service1,481,331,000USDDisclosure
    FY 2020Yearly · 2020-12-31ProductHospitals Contracts218,495,000USDDisclosure
    FY 2020Yearly · 2020-12-31ProductProduct And Service Other34,125,000USDDisclosure
    FY 2019Yearly · 2019-12-31ProductHealth Care Patient Service1,567,624,000USDDisclosure
    FY 2019Yearly · 2019-12-31ProductHospitals Contracts197,340,000USDDisclosure
    FY 2019Yearly · 2019-12-31ProductProduct And Service Other14,795,000USDDisclosure
    FY 2018Yearly · 2018-12-31ProductHealth Care Patient Service1,529,561,000USDDisclosure
    FY 2018Yearly · 2018-12-31ProductHospitals Contracts181,050,000USDDisclosure
    FY 2018Yearly · 2018-12-31ProductProduct And Service Other12,496,000USDDisclosure

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.